LifeVantage to Announce First Quarter Fiscal Year 2025 Results on October 29, 2024
LifeVantage (Nasdaq:LFVN), a health and wellness company focusing on cellular health, has announced it will release its first quarter fiscal year 2025 financial results on October 29, 2024, after the stock market closes. The company will host a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) on the same day.
Investors can participate in the live call by dialing (877) 704-4453 from the U.S. or (201) 389-0920 for international callers. A telephone replay will be available until November 12, 2024. Additionally, a live webcast will be accessible on the company's Investor Relations website, with an archive available for approximately 30 days.
LifeVantage (Nasdaq:LFVN), un azienda attiva nel settore della salute e del benessere focalizzata sulla salute cellulare, ha annunciato che rilascerà i propri risultati finanziari del primo trimestre dell'anno fiscale 2025 il 29 ottobre 2024, dopo la chiusura del mercato azionario. L'azienda ospiterà una conference call per gli investitori alle 14:30 ora di Montagna (16:30 ora dell'Est) nello stesso giorno.
Gli investitori possono partecipare alla chiamata dal vivo componendo il (877) 704-4453 dagli Stati Uniti o il (201) 389-0920 per le chiamate internazionali. Una registrazione telefonica sarà disponibile fino al 12 novembre 2024. Inoltre, un webcast dal vivo sarà accessibile sul sito web delle Relazioni con gli Investitori dell'azienda, con un archivio disponibile per circa 30 giorni.
LifeVantage (Nasdaq:LFVN), una empresa dedicada a la salud y el bienestar centrada en la salud celular, ha anunciado que publicará sus resultados financieros del primer trimestre del año fiscal 2025 el 29 de octubre de 2024, después del cierre del mercado de valores. La empresa realizará una llamada de conferencia para inversores a las 2:30 p.m. Hora Montañosa (4:30 p.m. Hora del Este) en el mismo día.
Los inversores pueden participar en la llamada en vivo marcando el (877) 704-4453 desde los EE.UU. o el (201) 389-0920 para llamadas internacionales. Se dispondrá de una grabación telefónica hasta el 12 de noviembre de 2024. Además, habrá un webcast en vivo accesible en el sitio web de Relaciones con Inversores de la empresa, con un archivo disponible durante aproximadamente 30 días.
LifeVantage (Nasdaq:LFVN)은 세포 건강을 중심으로 한 건강 및 웰빙 회사로, 2025 회계연도 첫 분기 재무 결과를 2024년 10월 29일 주식 시장 마감 후 발표할 것이라고 전했습니다. 회사는 같은 날 오후 2시 30분(동부 시간 오후 4시 30분)에 투자자를 위한 컨퍼런스 콜을 진행할 예정입니다.
투자자들은 미국에서 (877) 704-4453로, 또는 국제 전화는 (201) 389-0920으로 전화하여 실시간 콜에 참여할 수 있습니다. 전화 녹음은 2024년 11월 12일까지 이용 가능합니다. 또한, 회사의 투자자 관계 웹사이트에서 실시간 웹캐스트에 접근할 수 있으며, 약 30일 동안 아카이브를 이용할 수 있습니다.
LifeVantage (Nasdaq:LFVN), une entreprise axée sur la santé et le bien-être se concentrant sur la santé cellulaire, a annoncé qu'elle publiera ses résultats financiers du premier trimestre de l'exercice 2025 le 29 octobre 2024, après la fermeture du marché boursier. L'entreprise organisera une conférence téléphonique pour les investisseurs à 14h30, heure des Montagnes (16h30, heure de l'Est) le même jour.
Les investisseurs peuvent participer à l'appel en direct en composant le (877) 704-4453 depuis les États-Unis ou le (201) 389-0920 pour les appelants internationaux. Un enregistrement téléphonique sera disponible jusqu'au 12 novembre 2024. De plus, un webinaire en direct sera accessible sur le site des Relations avec les Investisseurs de l'entreprise, avec un enregistrement disponible pendant environ 30 jours.
LifeVantage (Nasdaq:LFVN), ein Unternehmen für Gesundheit und Wellness, das sich auf Zellgesundheit spezialisiert hat, hat angekündigt, dass es seine finanziellen Ergebnisse für das erste Quartal des Geschäftsjahres 2025 am 29. Oktober 2024 nach Börsenschluss veröffentlichen wird. Dass Unternehmen wird am selben Tag um 14:30 Uhr Mountain Time (16:30 Uhr Eastern Time) eine Konferenzschaltung für Investoren veranstalten.
Investoren können an dem Live-Anruf teilnehmen, indem sie (877) 704-4453 aus den USA oder (201) 389-0920 für internationale Anrufer wählen. Eine telefonische Wiederholung wird bis zum 12. November 2024 verfügbar sein. Darüber hinaus wird ein Live-Webcast auf der Investor-Relations-Website des Unternehmens zugänglich sein, mit einem Archiv, das ungefähr 30 Tage lang verfügbar ist.
- None.
- None.
SALT LAKE CITY, Oct. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended September 30, 2024, after the stock market closes on Tuesday, October 29, 2024. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.
Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours after the call concludes and will be available through Tuesday, November 12, 2024, by dialing (844) 512-2921 from the U.S. and entering confirmation code 13749350, or (412) 317-6671 from international locations, and entering confirmation code 13749350.
There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at https://lifevantage.gcs-web.com/events-and-presentations or directly at https://viavid.webcasts.com/starthere.jsp?ei=1691932&tp_key=975c2e4123. The webcast will be archived for approximately 30 days.
About LifeVantage Corporation
LifeVantage Corporation® (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs to optimize cellular function—just as nature intended. LifeVantage owns the identification, research, development, formulation, and sale of advanced nutrigenomic activators. The line of scientifically validated dietary supplements includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the AM/PM System, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own sales business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
FAQ
When will LifeVantage (LFVN) release its Q1 2025 financial results?
How can investors participate in LifeVantage's (LFVN) Q1 2025 earnings call?
Will there be a webcast available for LifeVantage's (LFVN) Q1 2025 earnings call?
Until what date will the telephone replay of LifeVantage's (LFVN) Q1 2025 earnings call be available?
